Full video transcriptClick to expand
Auto-generated transcript of @lavish_krish's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00If you have hollow under eyes, throw away your under eye patches immediately because
- 0:03nothing is as effective as walli filling.
- 0:06I mean, there's a reason why Koreans have flawless under eyes and it's because they
- 0:10incorporate products that contain walli filling.
- 0:13One I've been living recently is a skin 104 Metricxel 10% boosting shot at build because
- 0:19it has 5% walli filling, which is a plant-based ingredient to plump and smooth the skin.
- 0:24It also has these little spicules which makes the ingredients absorb a lot better, but I
- 0:29will say you won't see a visible difference in like two days.
- 0:33You have to use this consistently to see a gradual and visible difference.
Volufiline and matrixyl for hollow eyes: what the evidence says
Quick answer
Periorbital hollowing involves structural fat compartment loss and ligamentous changes that topical ingredients cannot fully address. Volufiline (sarsasapogenin-based) has limited independent clinical data specifically for the under-eye area, with most evidence derived from manufacturer studies on other body regions. The SKIN1004 product also contains Matrixyl (a palmitoyl peptide), which has stronger peer-reviewed support for periorbital skin quality improvement than volufiline does.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Volufiline and matrixyl for hollow eyes: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Volufiline and matrixyl for hollow eyes: what the evidence says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Volufiline and matrixyl for hollow eyes: what the evidence says" from Krishna. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Periorbital hollowing involves structural fat compartment loss and ligamentous changes that topical ingredients cannot fully address.
The reason this review is not generic is the source wording and the canonical claim label "peptides ad if you ask me hollow under eyes are pretty but if it both." In this clip, the useful excerpt is: "If you have hollow under eyes, throw away your under eye patches immediately because nothing is as effective as walli filling." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Periorbital hollowing involves structural fat compartment loss and ligamentous changes that topical ingredients cannot fully address.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Periorbital hollowing involves structural fat compartment loss and ligamentous changes that topical ingredients cannot fully address. Volufiline (sarsasapogenin-based) has limited independent clinical data specifically for the under-eye area, with most evidence derived from manufacturer studies on other body regions. The SKIN1004 product also contains Matrixyl (a palmitoyl peptide), which has stronger peer-reviewed support for periorbital skin quality improvement than volufiline does.
- Volufiline's primary clinical data comes from manufacturer-sponsored studies on bust and body areas, not the periorbital zone. Independent under-eye trials are lacking as of 2024.
- Hyaluronic acid fillers remain the gold standard for structural periorbital hollowing, with multiple peer-reviewed trials behind them (Funt and Pavicic, 2013).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Volufiline's primary clinical data comes from manufacturer-sponsored studies on bust and body areas, not the periorbital zone. Independent under-eye trials are lacking as of 2024.
- Hyaluronic acid fillers remain the gold standard for structural periorbital hollowing, with multiple peer-reviewed trials behind them (Funt and Pavicic, 2013).
- Matrixyl (palmitoyl pentapeptide-4), also in this product, has stronger independent evidence for improving periorbital skin texture and fine lines than volufiline does.
- Spicule-based penetration enhancement is a real cosmetic mechanism but can cause irritation around the thin, sensitive periorbital skin in some users.
- This video was a paid advertisement. The 'throw away your patches' framing is marketing language, not a clinically supported recommendation.
- Periorbital hollowing is structural. No topical product reverses fat compartment deflation or ligament laxity, which are the underlying causes in most cases.
- The creator's timeline advice (expect gradual results with consistent use) was accurate and more grounded than typical influencer product claims.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @lavish_krish actually say?
The creator told 442,000 viewers to "throw away your under eye patches immediately" because "nothing is as effective as volufiline filling." They credited Korean skincare routines for "flawless under eyes" specifically because of volufiline use, and claimed their SKIN1004 product contains 5% volufiline plus spicules that improve ingredient absorption. They did add one important caveat: "you won't see a visible difference in like two days" and consistent use is required for gradual results.
This is a paid advertisement (labeled #ad), which matters for how you weigh the enthusiasm. The creator is not a dermatologist or cosmetic scientist. The core claims, that volufiline plumps hollow under eyes and that under-eye patches are effectively useless by comparison, deserve actual scrutiny.
Does the science back this up?
Volufiline has some real evidence behind it, but not nearly as much as this video implies. It is a trademarked ingredient made from sarsasapogenin extracted from Anemarrhena asphodeloides, combined with hydrogenated polyisobutene. The proposed mechanism is stimulating lipid accumulation in adipocytes, essentially encouraging fat cell volume in the treated area.
One industry-sponsored in vitro and in vivo study (Sederma, the manufacturer) reported increased adipose tissue volume after topical application. An independent 2009 study by Pillaiyar et al. published in the Journal of Cosmetic Dermatology examined sarsasapogenin derivatives and noted biological activity in fat tissue models, though not specifically for periorbital hollowing. The honest problem here is that most volufiline research is either manufacturer-funded, conducted in cell cultures, or done on body areas like the bust and buttocks, not the delicate periorbital zone. Extrapolating those results to hollow tear troughs is a significant leap.
What did they get wrong (or right)?
Let's be direct. "Nothing is as effective as volufiline" for hollow under eyes is a claim without comparative clinical trial support. Hyaluronic acid fillers, for instance, have extensive peer-reviewed evidence for periorbital volume restoration (Funt and Pavicic, 2013, Journal of Clinical and Aesthetic Dermatology). Saying a topical ampoule beats filler, or even well-formulated peptide eye creams, is not a defensible position.
The "Koreans have flawless under eyes because of volufiline" framing is cultural mythology dressed as skincare science. Korean beauty routines involve multiple overlapping habits including sun protection, diet, hydration, and layered skincare, none of which can be isolated to a single ingredient.
What they got right: the expectation-setting on timeline. Telling viewers not to expect results in two days, and that consistency matters, is accurate and more responsible than most influencer skincare content. The mention of spicules as a penetration enhancer also reflects real cosmetic chemistry, though spicule-containing products carry their own skin sensitivity considerations that went unmentioned.
What should you actually know?
Hollow under eyes, clinically called periorbital hollowing or tear trough deformity, result from a combination of fat compartment deflation, skin thinning, and ligament changes that occur with age or are simply genetic. No topical ingredient reverses those structural changes the way a hyaluronic acid filler or fat transfer procedure can.
That does not mean topical products are useless. Ingredients like retinoids (Kafi et al., 2007, Archives of Dermatology), caffeine, peptides like Matrixyl (palmitoyl pentapeptide-4), and broad-spectrum SPF all have evidence for improving skin quality in the periorbital area. Volufiline at 5% may offer modest plumping through temporary lipid accumulation, but calling it a replacement for patches or other proven actives overstates what a single clinical mechanism can do.
If hollow under eyes are a genuine concern, a dermatologist consultation is a better starting point than a TikTok ad. And no, you probably do not need to throw away your eye patches.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Krishna · TikTok creator
442.6K views on this video
ad If you ask me hollow under eyes are pretty but if it bothers you I would def try @SKIN1004 US matrixyl 10 boosting shot ampoule 🩷 that contains 5% volufiline for hollow under eyes and dark circles 👏🏼 #skin1004 #volufiline #tiredeyes #centella #skincare
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about volufiline's primary clinical data comes from manufacturer-sponsored studies on bust?
Volufiline's primary clinical data comes from manufacturer-sponsored studies on bust and body areas, not the periorbital zone. Independent under-eye trials are lacking as of 2024.
What does the video say about hyaluronic acid fillers remain the gold standard for structural periorbital?
Hyaluronic acid fillers remain the gold standard for structural periorbital hollowing, with multiple peer-reviewed trials behind them (Funt and Pavicic, 2013).
What does the video say about matrixyl (palmitoyl pentapeptide-4), also in this product, has stronger independent?
Matrixyl (palmitoyl pentapeptide-4), also in this product, has stronger independent evidence for improving periorbital skin texture and fine lines than volufiline does.
What does the video say about spicule-based penetration enhancement?
Spicule-based penetration enhancement is a real cosmetic mechanism but can cause irritation around the thin, sensitive periorbital skin in some users.
What does the video say about this video was a paid advertisement. the 'throw away your?
This video was a paid advertisement. The 'throw away your patches' framing is marketing language, not a clinically supported recommendation.
What does the video say about periorbital hollowing?
Periorbital hollowing is structural. No topical product reverses fat compartment deflation or ligament laxity, which are the underlying causes in most cases.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Krishna, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.